Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing
Green Market Report
Wed, Nov 20
Key Points
- Psyence Biomedical Ltd. (Nasdaq: PBM) will undergo a 1-for-75 share consolidation.
- The consolidation is aimed at helping the company retain its Nasdaq listing.
- The change will be effective at market open on Nov. 26, with shares still trading under the ticker PBM.
- More details about the consolidation can be accessed by logging into the platform.
Psyence Biomedical Ltd. (Nasdaq: PBM) will implement a 1-for-75 share consolidation next week as the psychedelics company works to maintain its Nasdaq listing, the company said Tuesday.
The consolidation will take effect at market open on Nov. 26, with shares continuing to trade under the ticker PBM, the New York-based company...
Please login to read all 232 words.
Discover